AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33838756 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 vaccine (low dose)
Number of subjects: 0
Study 33838756 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 vaccine (high dose)
Number of subjects: 0
Study 33838756 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo or alternative treatment not specified)
Number of subjects: 0
Study 35880264 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised functional level‐based exercise program (40 min, 5 times a week during hospitalization)
Number of subjects: 124
Study 35880264 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised functional level‐based exercise program
Number of subjects: 124
Study 34489928 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous dendritic cells (DCs) administered in combination with neoadjuvant chemotherapy (NAC-AC)
Number of subjects: 20
Study 34489928 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NAC-AC) without DCs (control group)
Number of subjects: 20
Study 36107991 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resistance inspiratory muscle strength training (75% PIMAX)
Number of subjects: 128
Study 36107991 — intervention group
Group type: COMPARATOR
Intervention: Low-resistance sham training (15% PIMAX)
Number of subjects: 128
Study 34801061 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART program (self-management intervention)
Number of subjects: 0
Study 34801061 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 33404004 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandrax use
Number of subjects: 500
Study 33404004 — intervention group
Group type: EXPERIMENTAL
Intervention: Other substance use (heavy drinking, marijuana, methamphetamine)
Number of subjects: 500
Study 35807836 — intervention group
Group type: EXPERIMENTAL
Intervention: C. rabens extract capsule
Number of subjects: 40
Study 35807836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32352676 — intervention group
Group type: EXPERIMENTAL
Intervention: Contractubex gel applied 3 times a day for 9 months
Number of subjects: 60
Study 32352676 — intervention group
Group type: COMPARATOR
Intervention: No regular therapy (control group)
Number of subjects: 60
Study 35129111 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic
Number of subjects: 71
Study 35129111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 32883514 — intervention group
Group type: EXPERIMENTAL
Intervention: High antimüllerian hormone (AMH) levels in women with PCOS
Number of subjects: 264
Study 32883514 — intervention group
Group type: COMPARATOR
Intervention: Unexplained infertility cohort
Number of subjects: 264
Study 32446208 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (HV) in sitting position
Number of subjects: 20
Study 32446208 — intervention group
Group type: COMPARATOR
Intervention: Hyperventilation (HV) in supine position
Number of subjects: 20
Study 32446208 — intervention group
Group type: COMPARATOR
Intervention: Hyperventilation (HV) in supine position (younger age group 4-7 years)
Number of subjects: 20
Study 32446208 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (HV) in sitting position (younger age group 4-7 years)
Number of subjects: 20
Study 36180156 — intervention group
Group type: EXPERIMENTAL
Intervention: Hold-relax PNF
Number of subjects: 28
Study 36180156 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral lumbar mobilization (LM)
Number of subjects: 28
Study 36180156 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study 34560705 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychological intervention + care as usual
Number of subjects: 68
Study 34560705 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 68
Study 36193181 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX + LIDO
Number of subjects: 26
Study 36193181 — intervention group
Group type: COMPARATOR
Intervention: LIDO alone
Number of subjects: 26
Study 33494045 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s) during jump landing
Number of subjects: 41
Study 33494045 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s) during dominant leg cutting
Number of subjects: 41
Study 33494045 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task (subtracting by 6s or 7s)
Number of subjects: 41
Study 33852258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide-containing sunscreen
Number of subjects: 0
Study 33852258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide-containing moisturizing cream
Number of subjects: 0
Study 33059610 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent non-pharmacological intervention (MAKS-s)
Number of subjects: 144
Study 33059610 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (waitlist control group)
Number of subjects: 144
Study 36188642 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvogyl
Number of subjects: 0
Study 36188642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutanplast
Number of subjects: 0
Study 36188642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34418987 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief text messaging intervention (StAR2D)
Number of subjects: 0
Study 32835925 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil (10 mg/day)
Number of subjects: 30
Study 32835925 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 36198467 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 66
Study 36198467 — intervention group
Group type: EXPERIMENTAL
Intervention: RT combined with balance training
Number of subjects: 66
Study 36198467 — intervention group
Group type: COMPARATOR
Intervention: Control group with usual daily activities
Number of subjects: 66
Study 36198467 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (RT, RT with balance training, Control)
Number of subjects: 66
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: CA125
Number of subjects: 43
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: HE4
Number of subjects: 43
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: OPN
Number of subjects: 43
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: leptin
Number of subjects: 43
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: prolactin
Number of subjects: 43
Study 34530759 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistical regression model (CA125, HE4, OPN, leptin, prolactin)
Number of subjects: 43
Study 32387067 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior myocardial infarction (MI)
Number of subjects: 8916
Study 32387067 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-enrollment myocardial infarction (MI)
Number of subjects: 8916
Study 37127433 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 ppm fluoride toothpaste
Number of subjects: 24
Study 37127433 — intervention group
Group type: COMPARATOR
Intervention: 1450 ppm fluoride toothpaste
Number of subjects: 24
Study 33651633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Resistance Training (DRT)
Number of subjects: 197
Study 33651633 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric Resistance Training (IRT)
Number of subjects: 197
Study 33651633 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 197
Study 32730946 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right posterior parietal cortex (1 mA, 20 min)
Number of subjects: 19
Study 32730946 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 19
Study 32730946 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right posterior parietal cortex
Number of subjects: 19
Study 34215557 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNTAX score assessment by 6 clinicians
Number of subjects: 50
Study 34215557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-observer reliability of risk classification scores
Number of subjects: 50
Study 33904792 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture (LA) plus conventional treatment
Number of subjects: 59
Study 33904792 — intervention group
Group type: COMPARATOR
Intervention: Sham control (LA without laser output plus conventional treatment)
Number of subjects: 59
Study 35971655 — intervention group
Group type: EXPERIMENTAL
Intervention: galcanezumab-120 mg
Number of subjects: 1113
Study 35971655 — intervention group
Group type: EXPERIMENTAL
Intervention: galcanezumab-240 mg
Number of subjects: 1113
Study 35971655 — intervention group
Group type: EXPERIMENTAL
Intervention: previous-galcanezumab-120 mg
Number of subjects: 1113
Study 35971655 — intervention group
Group type: EXPERIMENTAL
Intervention: previous-galcanezumab-240 mg
Number of subjects: 1113
Study 35971655 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1113
Study 35971655 — intervention group
Group type: EXPERIMENTAL
Intervention: galcanezumab groups
Number of subjects: 1113
Study 34851211 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (30 sessions of home-based virtual reality rehabilitation system training, 5 sessions per week, each lasting 45 minutes)
Number of subjects: 70
Study 34851211 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 70
Study 34851211 — intervention group
Group type: COMPARATOR
Intervention: Usual care (30 sessions of conventional treatment, 5 sessions per week)
Number of subjects: 70
Study 32909675 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg)
Number of subjects: 305
Study 32909675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 36081429 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative nursing and psychological interventions
Number of subjects: 98
Study 36081429 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 98
Study 34511499 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity program with goal-setting and mentor support
Number of subjects: 52
Study 34511499 — intervention group
Group type: COMPARATOR
Intervention: Home-based physical activity program with education and peer contact
Number of subjects: 52
Study 35417301 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979
Study 35417301 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979
Study 35417301 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli-produced HPV-16/18 bivalent vaccine
Number of subjects: 979
Study 33807782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomics climate assessment at Besat power plant
Number of subjects: 219
Study 33807782 — intervention group
Group type: COMPARATOR
Intervention: Ergonomics climate assessment at Rey power plant
Number of subjects: 219
Study 33807782 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall ergonomics climate score
Number of subjects: 219
Study 33807782 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall ergonomics climate score and some subscales
Number of subjects: 219
Study 33807782 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomics climate score in employees with musculoskeletal pain
Number of subjects: 219
Study 32712034 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger Point Injections (TPIs) with 1% lidocaine
Number of subjects: 0
Study 32712034 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard conventional approach)
Number of subjects: 0
Study 35168963 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored multidimensional intervention (6 months duration, including three home visits, six home-based telephone calls, and one peer-support session)
Number of subjects: 110
Study 35168963 — intervention group
Group type: COMPARATOR
Intervention: Simple educational instructions at a single visit (control group)
Number of subjects: 110
Study 32947415 — intervention group
Group type: EXPERIMENTAL
Intervention: Densitometry distribution analysis (DDA)
Number of subjects: 196
Study 32947415 — intervention group
Group type: EXPERIMENTAL
Intervention: DDA
Number of subjects: 196
Study 32947415 — intervention group
Group type: COMPARATOR
Intervention: Traditional corneal densitometry
Number of subjects: 196
Study 32285238 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life Therapy (QOLT)
Number of subjects: 21
Study 32285238 — intervention group
Group type: COMPARATOR
Intervention: Heart Healthy Education (HHE)
Number of subjects: 21
Study 32285238 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study 33727257 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + aflibercept
Number of subjects: 180
Study 33727257 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX6 - aflibercept
Number of subjects: 180
Study 34672767 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (4.1mmol NO3-/day; DNS)
Number of subjects: 11
Study 34672767 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate-rich beetroot juice (DNS)
Number of subjects: 11
Study 34672767 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study 34018423 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad-based male empowerment curriculum
Number of subjects: 580
Study 34018423 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 580
Study 32037644 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk about Children (Let's Talk) intervention
Number of subjects: 16
Study 37225286 — intervention group
Group type: EXPERIMENTAL
Intervention: TEER plus GDMT
Number of subjects: 348
Study 37225286 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 348
Study 33626254 — intervention group
Group type: EXPERIMENTAL
Intervention: xanomeline-trospium
Number of subjects: 182
Study 33626254 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 182
Study 33158079 — intervention group
Group type: EXPERIMENTAL
Intervention: 85 g of mango intake
Number of subjects: 0
Study 33158079 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 g of mango intake
Number of subjects: 0
Study 35079789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir/Lamivudine (DTG/3TC)
Number of subjects: 741
Study 35079789 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir Alafenamide-based regimen (TAF)
Number of subjects: 741
Study 33933933 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic ankle support
Number of subjects: 27
Study 33933933 — intervention group
Group type: COMPARATOR
Intervention: Normal running (without ankle support)
Number of subjects: 27
Study 33933933 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle in-/eversion
Number of subjects: 27
Study 33734099 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing intervention
Number of subjects: 86
Study 33734099 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 86
Study 32267058 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg once daily
Number of subjects: 0
Study 32267058 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg once daily
Number of subjects: 0
Study 32267058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32267058 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (DPP-4 inhibitor)
Number of subjects: 0
Study 32267058 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin (SGLT-2 inhibitor)
Number of subjects: 0
Study 32267058 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide (subcutaneous GLP-1RA)
Number of subjects: 0
Study 32267058 — intervention group
Group type: COMPARATOR
Intervention: Dulaglutide (subcutaneous GLP-1RA)
Number of subjects: 0
Study 32750212 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 61
Study 32750212 — intervention group
Group type: COMPARATOR
Intervention: Core needle biopsy (CNB)
Number of subjects: 61
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + MICT
Number of subjects: 99
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + high-volume HIIT
Number of subjects: 99
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + low-volume HIIT
Number of subjects: 99
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: No Metformin + MICT
Number of subjects: 99
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: No Metformin + high-volume HIIT
Number of subjects: 99
Study 32456272 — intervention group
Group type: EXPERIMENTAL
Intervention: No Metformin + low-volume HIIT
Number of subjects: 99
Study 32456272 — intervention group
Group type: COMPARATOR
Intervention: No Metformin
Number of subjects: 99
Study 32456272 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 99
Study 36321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI vFFR
Number of subjects: 50
Study 36321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI FFR
Number of subjects: 50
Study 36321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between vFFR and FFR
Number of subjects: 50
Study 36321612 — intervention group
Group type: EXPERIMENTAL
Intervention: vFFR predicting FFR <0.90
Number of subjects: 50
Study 34407884 — intervention group
Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 100
Study 34407884 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 100
Study 36376888 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax combined with low dose cytarabine (VEN + LDAC)
Number of subjects: 156
Study 36376888 — intervention group
Group type: COMPARATOR
Intervention: Standard of care intensive chemotherapy (IC)
Number of subjects: 156
Study 32242215 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant Events Program (PEP)
Number of subjects: 123
Study 32242215 — intervention group
Group type: COMPARATOR
Intervention: Information and Support (IS)
Number of subjects: 123
Study 36152639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide (5 mg, 10 mg, or 15 mg)
Number of subjects: 2002
Study 36152639 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (100 U/mL)
Number of subjects: 2002
Study 36152639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Number of subjects: 2002
Study 36152639 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 2002
Study 34810346 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinwheel breathing exercise
Number of subjects: 60
Study 34810346 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic breathing exercise
Number of subjects: 60
Study 35943913 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-incision negative-pressure therapy
Number of subjects: 75
Study 35943913 — intervention group
Group type: COMPARATOR
Intervention: Adhesive strips
Number of subjects: 75
Study 34162822 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger mouthwash (20 ccs three times daily for 14 days)
Number of subjects: 105
Study 34162822 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera mouthwash (20 ccs three times daily for 14 days)
Number of subjects: 105
Study 34162822 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group, 20 ccs three times daily for 14 days)
Number of subjects: 105
Study 33805040 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified, combined protocol for severe and moderate acute malnutrition (SAM and MAM)
Number of subjects: 0
Study 33805040 — intervention group
Group type: COMPARATOR
Intervention: Standard care that treats SAM and MAM separately
Number of subjects: 0
Study 33805040 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 0
Study 33805040 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 34977957 — intervention group
Group type: EXPERIMENTAL
Intervention: ART adherence during lockdown
Number of subjects: 152
Study 34977957 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-being scores
Number of subjects: 152
Study 34977957 — intervention group
Group type: EXPERIMENTAL
Intervention: Violence, depression, food insecurity, and stigma
Number of subjects: 152
Study 33687606 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test (FIT) outreach program
Number of subjects: 60187
Study 33687606 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60187
Study 33687606 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT (ordered)
Number of subjects: 60187
Study 32518932 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg orally 2 hours prior to surgery
Number of subjects: 181
Study 32518932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 33155521 — intervention group
Group type: EXPERIMENTAL
Intervention: Family caregiver both at baseline and follow-up (n=74)
Number of subjects: 2294
Study 33155521 — intervention group
Group type: EXPERIMENTAL
Intervention: Family caregiver at baseline but not at follow-up (n=226)
Number of subjects: 2294
Study 33155521 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caregiver at baseline but family caregiver at follow-up (n=218)
Number of subjects: 2294
Study 33155521 — intervention group
Group type: COMPARATOR
Intervention: Non-caregiver both at baseline and follow-up (n=1776)
Number of subjects: 2294
Study 35762025 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine specific gravity guided fluids
Number of subjects: 80
Study 35762025 — intervention group
Group type: COMPARATOR
Intervention: Standard parameters for maintaining postnatal weight loss
Number of subjects: 80
Study 34165503 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP (docetaxel, trastuzumab, and pertuzumab) - 6 cycles
Number of subjects: 202
Study 34165503 — intervention group
Group type: COMPARATOR
Intervention: T-DM1 (trastuzumab emtansine) - monotherapy
Number of subjects: 202
Study 34165503 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP (docetaxel, trastuzumab, and pertuzumab)
Number of subjects: 202